- Presentations
- 3
- Markets
- 1
Gomekli is a brand of Mirdametinib marketed by SpringWorks Therapeutics, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Mirdametinib
- Brand owner
- SpringWorks Therapeutics
- Registered in
- United States
- Strengths and forms
- 1 mg capsule, 2 mg capsule, 1 mg tablet for oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Gomekli 1 mg capsuleOral | SpringWorks Therapeutics | US FDA | Available on request |
| Gomekli 2 mg capsuleOral | SpringWorks Therapeutics | US FDA | Available on request |
| Gomekli 1 mg tablet for oral suspensionOral | SpringWorks Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Gomekli
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.